Whole-Body PET/CT with11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: Feasibility study and comparison with 123I-MIBG SPECT/CT

Journal of Nuclear Medicine

Volumn 47, Issue 10, 2006, Pages 1635-1642

  Franzius, Christiane ^a   Hermann, Klaudia ^a   Weckesser, Matthias ^a   Kopka, Klaus ^a   Juergens, Kai Uwe ^a   Vormoor, Josef ^a   Schober, Otmar ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

11C HED PET CT; 123I MIBG SPECT CT; Neuroblastoma; Pheochromocytoma; Sympathetic nervous system tumors

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 3 HYDROXYEPHEDRINE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; (3 IODOBENZYL)GUANIDINE; 3 HYDROXYEPHEDRINE; 3-HYDROXYEPHEDRINE; CARBON; DIAGNOSTIC AGENT; DRUG DERIVATIVE; EPHEDRINE; RADIOACTIVE IODINE;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BONE DISEASE; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; FALSE POSITIVE RESULT; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; NERVOUS SYSTEM TUMOR; NEUROBLASTOMA; PARAGANGLIOMA; PATIENT ASSESSMENT; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RADIATION ATTENUATION; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOFT TISSUE DISEASE; WHOLE BODY CT; WHOLE BODY PET; ADOLESCENT; AUTONOMIC NEUROPATHY; COMPARATIVE STUDY; INFANT; MIDDLE AGED; PERIPHERAL NERVE TUMOR; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; RADIOGRAPHY; SCINTISCANNING; WHOLE BODY IMAGING;

3-IODOBENZYLGUANIDINE; ADOLESCENT; ADULT; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; CARBON RADIOISOTOPES; CHILD; CHILD, PRESCHOOL; EPHEDRINE; FEASIBILITY STUDIES; FEMALE; HUMANS; INFANT; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 34247179545     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kushner BH. Neuroblastoma: a disease requiring a multitude of imaging studies. J Nucl Med. 2004;45:1172-1188.
2. Pfluger T, Schmied C, Porn U, et al. Integrated imaging using MRI and I-123-metaiodobenzylguanidine scintigraphy to improve sensitivity and specificity in the diagnosis of pediatric neuroblastoma. AJR. 2003;181:1115-1124.
3. Langer O, Halldin C. PET and SPET tracers for mapping the cardiac nervous system. Eur J Nucl Med Mol Imaging. 2002;29:416-434.
4. Rosenspire KC, Haka MS, Van Dort ME, et al. Synthesis and preliminary evaluation of C-11 metahydroxyephedrine: a false neurotransmitter agent for heart neurological imaging. J Nucl Med. 1990;31:1328-1334.
5. Shulkin BL, Wieland DM, Schwaiger M, et al. PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med. 1992;33:1125-1131.
6. Shulkin BL, Wieland DM, Baro ME, et al. PET hydroxyephedrine imaging of neuroblastoma. J Nucl Med. 1996;37:16-21.
7. Trampal C, Engler H, Juhlin C, Bergström M, Langström B. Pheochromocytomas: detection with C-11 hydroxyephedrine PET. Radiology. 2004;230:423-428.
8. Mann GN, Link JM, Pham P, et al. [C-11]Metahydroxyephedrine and [F-18] fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma. Ann Surg Oncol. 2006;13:187-197.
9. Franzius C, Riemann B, Vormoor J, et al. Metastatic neuroblastoma demonstrated by whole-body PET-CT using C-11-HED. Nuklearmedizin. 2005;44:N4-N5.
10. Pfannenberg AC, Eschmann SM, Hoger M, et al. Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms. Eur J Nucl Med Mol Imaging. 2003;30:835-843.
11. Moreira SGJ, Pow-Sang JM. Evaluation and management of adrenal masses. Cancer Control. 2002;9:326-334.
12. Franzius C, Lang K, Wormanns D, Vormoor J, Schober O. PET/CT and PET: application in pediatric oncology [in German]. Der Nuklearmediziner. 2004;27:315-323.
13. Hoefnagel CA. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumors. Eur J Nucl Med. 1994;21:561-581.
14. Hahn K, Fischer S. Radiation dose and radiation protection from paediatric nuclear medicine procedures [in German]. Der Nuklearmediziner. 2002;25:90-100.
15. Mamede M, Carrasquillo JA, Chen CC, et al. Discordant localization of 2-[F-18]-fluoro-2-deoxy-D-glucose in 6-[F-18]-fluorodopamine- and [I-123]-metaiodobenzylguanidine-negative metastatic pheochromocytoma. Nucl Med Commun. 2006;27:31-36.
16. Hoegerle S, Nitzsche E, Altehoefer C, et al. Pheochromocytomas: detection with F18-DOPA whole-body PET - initial results. Radiology. 2002;222:507-512.
17. Becherer A, Szabó M, Karanikas G, et al. Imaging of advanced neuroendocrine tumors with F-18-FDOPA PET. J Nucl Med. 2004;45:1161-1167.